Braveheart Investment (BRH) AI Stock Analysis

• Market Cap: £1.77M
• Dividend Yield: N/A
• Average Volume (3M): 72.18K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.11
• Revenue Growth: -100.24%
• EPS Growth: 84.97%
• Country: UK
• Employees: 5
• Sector: Financial
• Sector Strength: 72
• Industry: Asset Management
• EPS (TTM): -0.02
• Shares Outstanding: 78,473,490
• 10 Day Avg. Volume: 17,605
• 30 Day Avg. Volume: 72,183
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 43 Neutral
• Price Target: ―

Braveheart Investment Group faces significant financial instability, marked by declining revenues and profitability issues, despite having no debt. Technical analysis indicates a bearish trend, with the stock trading below key moving averages and being oversold. Valuation metrics are unattractive due to a negative P/E ratio and no dividend yield. However, the recent strategic investment in IQ-AI Ltd is a positive development that might enhance its market position, but overall risks remain high.

Braveheart Investment Business Overview & Revenue Model

Company Description

Braveheart Investment Group plc is a private equity and venture capital firm specializing in seed, start-up, early stage, growth stage, expansion stage, growth capital, turnaround, restructuring, management buy-out, management buy-in, spinout, loan and mezzanine funding, and follow-on and secondary purchase stage investments in unquoted emerging companies. It also provides equity & equity-linked investments in growth, small and medium sized enterprises and B2B. The firm does not invest in any project involved in shipbuilding, coal, or steel sector; is involved in dealing in land, commodities, futures or the instruments of any holding company that are traded on a stock exchange, wholesale trade or retailing; former ECSC sectors; agriculture, aquaculture, fisheries, synthetic fibre, production; railway, road haulage, maritime and aviation transport companies; banking, insurance, money lending, debt factoring, hire purchase financing and other financial activities; leasing or letting assets on hire; providing legal or accountancy services; operating or managing hotel or nursing or residential care homes, film production, hotels, and property (although this may be considered as part of a wider transaction). It primarily invests in technology, manufacturing, food and drink, chemical, biosciences, healthcare, creative and digital industries, information and communications technology/software/telecoms/media, environmental technologies, financial and business services, sports sector, bio-medical, engineering, materials, information sciences, and computing technology sectors in the higher education sector, retail, and service industry based businesses. It also invests in debt. It typically invests in small and medium enterprises based in United Kingdom and Ireland. It prefers to invest in Yorkshire and Humber region. The firm seeks to invest between £0.010 million ($0.012 million) and £10 million ($15.71 million) in its portfolio companies but will also participate in larger syndicates where sums raised might be £5 million ($7.70 million) to £10 million ($15.41 million). It prefers to take minority stake and typically holds its investments for a period of two to five years. The firm prefers to take board seat and co-lead its investments. The firm also provides advisory services. Braveheart Investment Group plc was founded in 1997 and is based in Barnsley, United Kingdom with additional offices in Europe and Asia.

How the Company Makes Money

Braveheart Investment makes money primarily through management fees and performance fees associated with its asset management services. These fees are charged to clients based on the assets under management (AUM) and the performance of the investment portfolio. Additionally, the company generates revenue from its venture capital activities by investing in high-growth potential startups and earning returns on these investments. Financial advisory services also contribute to the company's earnings through consultancy fees. Strategic partnerships with financial institutions and co-investment opportunities further enhance Braveheart Investment's revenue streams by expanding its reach and leveraging shared resources.

Braveheart Investment Financial Statement Overview

Summary

Braveheart Investment exhibits financial instability with declining revenues and profitability issues. Despite a strong equity standing and no debt, cash flow inefficiencies and declining assets present significant financial challenges.

Income Statement

The income statement reveals significant volatility with a decline in revenue from 2021 to 2023, alongside negative net income in the most recent year. The company experienced a dramatic revenue drop after 2021, with a growth rate of 2579.88% in 2023 followed by a decline in 2024, indicating instability. The gross profit margin improved to 68.67% in 2024, but the net profit margin was negative at -531.16%, highlighting profitability challenges.

Balance Sheet

The balance sheet shows a strong equity position with no debt, improving the debt-to-equity ratio to 0. The equity ratio is robust at 97.04%, indicating financial stability. However, a significant decline in total assets over the years raises concerns about asset management.

Cash Flow

Cash flow analysis shows a negative operating cash flow and free cash flow, coupled with no financing activities, indicating liquidity issues. The free cash flow to net income ratio is also negative, reflecting cash flow inefficiencies.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.24M	20.50K	60.90K	50.90K	78.13K	7.85M
Gross Profit	1.24M	-274.18K	-366.56K	-505.24K	-558.01K	7.06M
EBITDA	-723.15K	-565.91K	-811.88K	-788.22K	-695.49K	5.28M
Net Income	-6.47M	-1.09M	-7.25M	1.58M	1.45M	13.94M
Balance Sheet
Total Assets	3.50M	2.39M	3.50M	11.61M	7.06M	3.20M
Cash, Cash Equivalents and Short-Term Investments	1.09M	63.67K	1.74M	934.86K	1.89M	2.14M
Total Debt	0.00	0.00	0.00	0.00	0.00	13.18K
Total Liabilities	43.60K	58.14K	104.14K	1.09M	449.86K	632.92K
Stockholders Equity	3.46M	2.33M	3.40M	10.52M	6.63M	2.57M
Cash Flow
Free Cash Flow	-438.17K	-541.01K	-736.12K	-768.19K	-1.28M	-1.29M
Operating Cash Flow	-438.17K	-541.01K	-736.12K	-768.19K	-1.27M	-1.28M
Investing Cash Flow	1.13M	-1.14M	1.54M	-1.08M	-1.40M	17.09M
Financing Cash Flow	0.00	0.00	0.00	930.36K	2.42M	-14.35M

Braveheart Investment Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2.25
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:BRH, the sentiment is Negative. The current price of 2.25 is below the 20-day moving average (MA) of 2.27, below the 50-day MA of 2.31, and below the 200-day MA of 3.86, indicating a bearish trend. The MACD of -0.03 indicates Negative momentum. The RSI at 36.35 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:BRH.

Braveheart Investment Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	58 Neutral	HK$112.05B	6.02	-4.20%	3.95%	9.29%	-46.28%
BSFA	52 Neutral	£2.50M	―	-46.41%	―	-64.18%	12.05%
MILA	48 Neutral	£3.26M	―	-10.47%	―	―	31.58%
GUN	47 Neutral	£1.47M	―	-34.06%	―	―	80.00%
BRH	43 Neutral	£1.77M	―	-38.03%	―	-100.24%	84.97%
BLU	―	£7.97M	―	-140.34%	―	―	―
CHP	44 Neutral	£2.92M	―	-71.01%	―	―	―

Braveheart Investment Corporate Events

Braveheart Investment Group Expands Stake in IQ-AI Ltd

Braveheart Investment Group plc has increased its stake in IQ-AI Ltd by subscribing to 7,000,000 new shares in a recent placing, raising its holding to 29.35% of IQ-AI’s enlarged share capital. This strategic investment is seen as a significant addition to Braveheart’s portfolio, potentially enhancing its market position and offering stakeholders increased value through IQ-AI’s innovative imaging platforms and therapeutics.